As of 2026-04-13, the Relative Valuation of Vincerx Pharma Inc (VINC) is (880.74) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.10 USD, the upside of Vincerx Pharma Inc based on Relative Valuation is -880838.6%.
The range of the Relative Valuation is (802.55) - (922.84) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 22.8x | 20.3x |
| Forward P/E multiples | 17.8x - 21.5x | 20.7x |
| Fair Price | (802.55) - (922.84) | (880.74) |
| Upside | -802646.2% - -922942.2% | -880838.6% |
| Date | P/E |
| 2026-04-07 | -0.00 |
| 2026-04-06 | -0.00 |
| 2026-04-02 | -0.00 |
| 2026-04-01 | -0.00 |
| 2026-03-31 | -0.00 |
| 2026-03-27 | -0.00 |
| 2026-03-26 | -0.00 |
| 2026-03-25 | -0.00 |
| 2026-03-24 | -0.00 |
| 2026-03-23 | -0.00 |
| 2026-03-19 | -0.00 |
| 2026-03-16 | -0.00 |
| 2026-03-12 | -0.00 |
| 2026-03-10 | -0.00 |
| 2026-03-09 | -0.00 |
| 2026-03-04 | -0.00 |
| 2026-03-02 | -0.00 |
| 2026-02-26 | -0.00 |
| 2026-02-25 | -0.00 |
| 2026-02-24 | -0.00 |
| 2026-02-19 | -0.00 |
| 2026-02-18 | -0.00 |
| 2026-02-17 | -0.00 |
| 2026-02-12 | -0.00 |
| 2026-02-10 | -0.00 |
| 2026-02-09 | -0.00 |
| 2026-02-06 | -0.00 |
| 2026-02-05 | -0.00 |
| 2026-02-04 | -0.00 |
| 2026-02-02 | -0.00 |
| 2026-01-30 | -0.00 |
| 2026-01-29 | -0.00 |
| 2026-01-28 | -0.00 |
| 2026-01-27 | -0.00 |
| 2026-01-26 | -0.00 |
| 2026-01-23 | -0.00 |
| 2026-01-22 | -0.00 |
| 2026-01-21 | -0.00 |
| 2026-01-20 | -0.00 |
| 2026-01-13 | -0.00 |